Healthcare platform corporations MetaRobotics said on the 28th that it posted 147.3 billion won in revenue, 21.2 billion won in operating profit, and 25.1 billion won in earnings before interest, taxes, depreciation and amortization (EBITDA) in 2025. Compared with the same period a year earlier, revenue rose 13% and operating profit increased 22%.
A MetaRobotics official said, "This earnings growth was driven by the growth of key affiliates and the expansion of overseas business," adding, "Exports of medical devices increased sharply, and the online platform business also grew stably, so the trend of improved profitability is continuing alongside revenue growth."
Affiliate METAPHARM's revenue increased 69% from a year earlier, and operating profit rose 92%. Subsidiary Ezen Implant, boosted by rising overseas sales of dental implants, won the "$10 million Export Tower" in December last year. In addition, demand is growing at home and abroad for the internally developed and manufactured PDO sutures for thread lifting "MiniTing" and the medical device for hair transplantation "MetaHair."
Another affiliate, TechLabs, said revenue increased on the back of growth in the healthcare marketing business and in Korea's No. 1 fortunetelling tech platform "Jeomsin." In particular, the fortune-based reward service "Lucky Bus" is rapidly expanding its user base through listings on major finance and lifestyle platforms such as Toss, Shinhan SOL Pay, and Hana Money.
This year, MetaRobotics plans to ramp up global expansion and upgrade its business portfolio. In July last year, the company signed a strategic memorandum of understanding (MOU) with Yas Healthcare under Das Holding, headquartered in Abu Dhabi, United Arab Emirates (UAE), and began moving into the Middle East and North Africa markets.
Through this, it plans to open a K-beauty medical center within the year in Business Bay, the central commercial district of Dubai. METAPHARM is reviewing strategic mergers and acquisitions (M&A) in high value-added medical devices such as fillers and Botox.
The company plans to strengthen global competitiveness and accelerate growth by expanding its product portfolio. TechLabs will expand its platform centered on Lucky Bus and pursue traffic growth and diversification of revenue models by broadening partnerships with major super apps.
Over the long term, it plans to expand its business areas into healthcare services and artificial intelligence (AI)-based personalized services, based on user data accumulated on the platform.
A MetaRobotics official said, "The K-beauty industry is rapidly shifting from a simple cosmetics-centered market to a high value-added, medical and procedure-based services market," adding, "Our company will leap forward as a total global K-beauty medical platform corporations that secures both scalability and profitability by combining our medical device manufacturing capabilities, digital platform technology, global network, and management consulting experience across various medical fields, including dermatology and plastic surgery as well as dentistry and Korean traditional medicine clinics."